BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 4186794)

  • 1. [Personal experience in the management of the post-menopausal patient using sequential 11 plus 10 therapy (mestranol 30 mcg. and chlormadinone 1 mlg. plus mestranol 80 mcg)].
    González Gutiérrez JT
    Ginecol Obstet Mex; 1969 May; 24(151):531-7. PubMed ID: 4186794
    [No Abstract]   [Full Text] [Related]  

  • 2. Sequential mestranol-chlormadinone acetate as an oral contraceptive.
    Tyler ET
    Obstet Gynecol; 1966 Dec; 28(6):787-92. PubMed ID: 4162518
    [No Abstract]   [Full Text] [Related]  

  • 3. Modified sequential oral contraception employing mestranol with chlormadinone.
    Tyler ET; Matsner EM; Gotlib M
    Obstet Gynecol; 1969 Dec; 34(6):820-4. PubMed ID: 4189147
    [No Abstract]   [Full Text] [Related]  

  • 4. [Experience in the use of chlormadinone acetate-mestranol mixed tablet (S-3850 tablet)].
    Toyama J; Murata H; Itakura E; Sumi K; Sugawara T
    Sanfujinka No Jissai; 1967 Apr; 16(4):364-72. PubMed ID: 4168671
    [No Abstract]   [Full Text] [Related]  

  • 5. [Inhibitors of human ovulation. General principles and accumulated experiences with sequential therapy based on mestranol and chlormadinone acetate].
    Zorrilla E
    Prensa Med Mex; 1968; 33(11):453-64. PubMed ID: 4105432
    [No Abstract]   [Full Text] [Related]  

  • 6. Our experience with sequential estrogen-progestin treatments to inhibit ovulation.
    Cittadini E; Quartararo P; Romano F
    Int J Fertil; 1969; 14(2):180-7. PubMed ID: 4181574
    [No Abstract]   [Full Text] [Related]  

  • 7. [Nonanouvlatory doses of sequential mestranol-chlormadinone combination in female acne].
    Romiti N
    An Bras Dermatol; 1971; 46(1):13-8. PubMed ID: 4108151
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical application of the mixture of mestranol and chlormadinone for functional anomaly of the ovary].
    Kobayshi T; Amenomori Y; Nagai N; Egusa M; Ichikawa T
    Saishin Igaku; 1966 Sep; 21(9):2089-94. PubMed ID: 4166819
    [No Abstract]   [Full Text] [Related]  

  • 9. [On the two-phase treatment with mestranol-chlormadinone acetate in dysfunctional hemorrhages, functional sterility and dys-or hypogonadotropic amenorrheas].
    Göretzlehner G
    Dtsch Gesundheitsw; 1967 Jun; 22(24):1124-6. PubMed ID: 4176451
    [No Abstract]   [Full Text] [Related]  

  • 10. [Studies on the contraceptive effects of periodic administration of mestranol 0.08mg and chlormadinone acetate 2mg (S-3850 tablets)].
    Kobayashi T; Amemori Y; Watanabe T; Ichikawa T
    Horumon To Rinsho; 1968 May; 16(5):403-9. PubMed ID: 4177677
    [No Abstract]   [Full Text] [Related]  

  • 11. [Steroid metabolism in primates. XVIII. Return to higher levels of 17-ketosteroid excretion in urine after ending a long-term treatment with mestranol/chlormadinone acetate in the baboon].
    Gontscharow NP; Woronzow WI; Schön R; Hobe G; Schubert K
    Endokrinologie; 1976 Jul; 67(3):362-4. PubMed ID: 61857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Endometrium during administration of sequence-ovosiston (report on 3 variants of sequential therapy)].
    Böhm W; Hempel E; Klinger G; Carol W
    Zentralbl Gynakol; 1972 Dec; 94(52):1816-20. PubMed ID: 4119792
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of mestranol and chlormadinone acetate on urinary excretion of FSH and LH.
    Stevens VC; Goldzieher JW; Vorys N
    Am J Obstet Gynecol; 1968 Sep; 102(1):95-105. PubMed ID: 4175034
    [No Abstract]   [Full Text] [Related]  

  • 14. Double-blind trial of a sequential oral contraceptive (Sequens) in the treatment of dysmenorrhoea.
    Matthews AE; Clarke JE
    J Obstet Gynaecol Br Commonw; 1968 Nov; 75(11):1117-22. PubMed ID: 4177921
    [No Abstract]   [Full Text] [Related]  

  • 15. [Experiences with the different dosage of Ovosiston preparations in the framework of marital and sexual counseling. Individual therapy with oral contraceptives].
    Ebeling K; Kühndel K; Rothe K
    Dtsch Gesundheitsw; 1971 Jan; 26(2):61-4. PubMed ID: 4106277
    [No Abstract]   [Full Text] [Related]  

  • 16. [Treatment of seborrheic conditions of the female scalp using modern combined peroral estrogen-gestagen preparations].
    Spirov G; Berova N; Vasilev D
    Vestn Dermatol Venerol; 1973 Jul; 47(7):30-3. PubMed ID: 4127925
    [No Abstract]   [Full Text] [Related]  

  • 17. Two thousand woman-years' experience with a sequential contraceptive. A more effective method of taking a sequential contraceptive.
    Karrer MC; Smith ER
    Am J Obstet Gynecol; 1968 Dec; 102(7):1029-34. PubMed ID: 4177693
    [No Abstract]   [Full Text] [Related]  

  • 18. [Advantage of the use of an estroprogestational drug: 3 mg of chlormadinone acetate + 100 mcg of mestranol in endocrine gynecology].
    Bernard I
    Bord Med; 1970; 3(7):1954-60. PubMed ID: 4195405
    [No Abstract]   [Full Text] [Related]  

  • 19. [Functional cytology of bovine adenohypophysis and the effects of mestranol and chlormadinone acetate].
    Schuffenhauer W; Lange W
    Arch Exp Veterinarmed; 1974; 28(5):749-58. PubMed ID: 4142925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Therapy of dysmenorrhea].
    Cazzola D
    Ann Ostet Ginecol Med Perinat; 1975; 96(3):189-201. PubMed ID: 59568
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.